Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22198788.
- Also identified by DOI 10.1093/cid/cir950.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical benefit of antiretroviral therapy in infants is established. In this cohort collaboration, we compare immunological and virological response to treatment started before or after 3 months of age. Early initiation provides a better short-term response, although evolution after 12 months of age is similar in both groups.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Viral Load